Wind River at a Glance Founded 1981, IPO 1993 42,000+ Developer Community Products running in 350+ million devices $328M Revenue FY08 $244M Cash $81M Annual R&D Investment 35%+ Commercial Market Share 450 Development Engineers 200 Support Engineers 300+ Professional Services North America, EMEA, APAC 1507 Employees Worldwide History & Experience  Financial Engineering
Wind River Professional Services Turnkey Design Solutions System Architecture System Design & Integration  Hardware / Software Design RTL / FPGA Development PCB & Reference Platforms Firmware Design Boot Code, Device Drivers, BSP RTOS: VxWorks, Linux, 3rd Party Software Design Development Environments Platform Customization Custom Middleware Algorithm / DSP development Cost optimization services  Device Packaging & Test Complete HW and SW solution, including…
Wind River and Medical Devices Operating Systems and Development Tools Complete Hardware/Software Solutions Image Processing Solutions Wired/Wireless Network Integration Custom Devices Process Audits Bayer Certification CMMI Level 3 Rated Zeiss  LSM 710 Siemens MAGNETOM Avanto 1.5T IntelliDot CAREt
Boston Scientific To Start-Ups: Don’t Call Us, We’ll Call You   Boston Scientific CEO Jim Tobin went out of his way in a speech last week to dissuade start-up firms from expecting investment from his company.  In the current climate, "It is only in almost rare instances that we get out our checkbook and write a check," Tobin said Nov. 12 at the Cleveland Clinic's Medical Innovation Summit in Cleveland.  "We have been spending $600 million a year for most of the 10 years that I have been involved in this thing," he said. But now "we are going to expect more from [small firms], and we are not going to overpay. The old days are over, and I don't think they are coming back."  In truth, Boston Scientific has emphasized sell-offs over technology acquisitions since well before the credit crisis mushroomed to its current level. The need to pay off the substantial debt created by the 2006 purchase of Guidant for $28 billion led the company to divest more than a billion dollars in assets in the past year. But Tobin suggests that the Guidant debt is no longer the primary factor defining Boston Scientific's investment strategy. The debt has declined from $8 billion a couple of years ago to its current level of $5 billion, and it is "coming down practically every day," he said in Cleveland.
Medical Devices Outlook Life Sciences sector set all-time record for VC investing $9.1 billion in 2007 in 862 deals,  Up from $7.6 billion in 786 deals in 2006.  Most significant growth in Medical Device industry Up 40 percent in 2007 to $3.9 billion going into 385 deals.  Source: National Venture Capital Association MoneyTree™ Report, 2007
Biomedical Employment Over 2,500 biomedical companies in California #1 - Bay Area: ~750 #2 - San Diego: ~525 63% expect to hire additional  R&D staff within California. 68% expanded in-state R&D  capacity in 2006, and expect to  expand their R&D activities in the  next two years
Local Funding Venture Capital In 2007, Almost half of all biomed dollars in US go to California companies About 35% goes to Medical Devices NIH The largest NIH California funding was in San Diego Burnham Institute for Medical Research; Salk Institute for Biological Studies San Diego State University University of California, San Diego;  SAIC Scripps Research Institute
The “Next Big Thing” in Medical Devices? Remote monitoring? Smart prosthetics? Sequencing and Synthetics? Tricorders?
Medical Devices Technology Device Sectors Consumer devices (blood glucose, smart monitor devices) Institutional devices (radiology, chemistry, imaging systems) Research devices (sequencers, analyzers, one-off devices) Challenges in Next-gen Medical Devices? Certification? Liability? Exploding Software Content Management Ease of Use (simple UI)? Connectivity and Data Access? Intellectual Property?  (Hardware vs Software) Confidentiality and Security?
The Top Ten MedTech Trends of 2009   According to  Global Markets Direct   The home healthcare equipment market is poised for a big return in 2009, owing to cost containment efforts by both providers and purchasers   Emerging medical equipment markets will continue to grow in 2009, assisted by the ongoing trend towards medical tourism and helping to offset any negative impact felt by the general economic downturn    Major medical equipment manufacturers to remain stable in spite of mounting financial crisis  Direct to consumer advertising of medical devices to continue to increase in prominence in 2009  Healthcare information technology spend to gain significant attention in 2009 and beyond from both developed and emerging economies
The Top Ten MedTech Trends of 2009   According to  Global Markets Direct Drug eluting stents on a comeback trail in the US market in 2009  Young adults and middle aged patients to drive the US market for hip resurfacing for next five years  Cash rich and innovative companies to benefit in the current economic scenario  Products related to women's health, minimally invasive surgery and home healthcare are set to garner special attention in 2009  High volume and low value of deals will be a norm in the medical equipment mergers and acquisitions landscape in 2009

VIP Roundtable - Medical Devices

  • 1.
    Wind River ata Glance Founded 1981, IPO 1993 42,000+ Developer Community Products running in 350+ million devices $328M Revenue FY08 $244M Cash $81M Annual R&D Investment 35%+ Commercial Market Share 450 Development Engineers 200 Support Engineers 300+ Professional Services North America, EMEA, APAC 1507 Employees Worldwide History & Experience Financial Engineering
  • 2.
    Wind River ProfessionalServices Turnkey Design Solutions System Architecture System Design & Integration Hardware / Software Design RTL / FPGA Development PCB & Reference Platforms Firmware Design Boot Code, Device Drivers, BSP RTOS: VxWorks, Linux, 3rd Party Software Design Development Environments Platform Customization Custom Middleware Algorithm / DSP development Cost optimization services Device Packaging & Test Complete HW and SW solution, including…
  • 3.
    Wind River andMedical Devices Operating Systems and Development Tools Complete Hardware/Software Solutions Image Processing Solutions Wired/Wireless Network Integration Custom Devices Process Audits Bayer Certification CMMI Level 3 Rated Zeiss LSM 710 Siemens MAGNETOM Avanto 1.5T IntelliDot CAREt
  • 4.
    Boston Scientific ToStart-Ups: Don’t Call Us, We’ll Call You Boston Scientific CEO Jim Tobin went out of his way in a speech last week to dissuade start-up firms from expecting investment from his company. In the current climate, "It is only in almost rare instances that we get out our checkbook and write a check," Tobin said Nov. 12 at the Cleveland Clinic's Medical Innovation Summit in Cleveland. "We have been spending $600 million a year for most of the 10 years that I have been involved in this thing," he said. But now "we are going to expect more from [small firms], and we are not going to overpay. The old days are over, and I don't think they are coming back." In truth, Boston Scientific has emphasized sell-offs over technology acquisitions since well before the credit crisis mushroomed to its current level. The need to pay off the substantial debt created by the 2006 purchase of Guidant for $28 billion led the company to divest more than a billion dollars in assets in the past year. But Tobin suggests that the Guidant debt is no longer the primary factor defining Boston Scientific's investment strategy. The debt has declined from $8 billion a couple of years ago to its current level of $5 billion, and it is "coming down practically every day," he said in Cleveland.
  • 5.
    Medical Devices OutlookLife Sciences sector set all-time record for VC investing $9.1 billion in 2007 in 862 deals, Up from $7.6 billion in 786 deals in 2006. Most significant growth in Medical Device industry Up 40 percent in 2007 to $3.9 billion going into 385 deals. Source: National Venture Capital Association MoneyTree™ Report, 2007
  • 6.
    Biomedical Employment Over2,500 biomedical companies in California #1 - Bay Area: ~750 #2 - San Diego: ~525 63% expect to hire additional R&D staff within California. 68% expanded in-state R&D capacity in 2006, and expect to expand their R&D activities in the next two years
  • 7.
    Local Funding VentureCapital In 2007, Almost half of all biomed dollars in US go to California companies About 35% goes to Medical Devices NIH The largest NIH California funding was in San Diego Burnham Institute for Medical Research; Salk Institute for Biological Studies San Diego State University University of California, San Diego; SAIC Scripps Research Institute
  • 8.
    The “Next BigThing” in Medical Devices? Remote monitoring? Smart prosthetics? Sequencing and Synthetics? Tricorders?
  • 9.
    Medical Devices TechnologyDevice Sectors Consumer devices (blood glucose, smart monitor devices) Institutional devices (radiology, chemistry, imaging systems) Research devices (sequencers, analyzers, one-off devices) Challenges in Next-gen Medical Devices? Certification? Liability? Exploding Software Content Management Ease of Use (simple UI)? Connectivity and Data Access? Intellectual Property? (Hardware vs Software) Confidentiality and Security?
  • 10.
    The Top TenMedTech Trends of 2009   According to Global Markets Direct The home healthcare equipment market is poised for a big return in 2009, owing to cost containment efforts by both providers and purchasers  Emerging medical equipment markets will continue to grow in 2009, assisted by the ongoing trend towards medical tourism and helping to offset any negative impact felt by the general economic downturn   Major medical equipment manufacturers to remain stable in spite of mounting financial crisis Direct to consumer advertising of medical devices to continue to increase in prominence in 2009 Healthcare information technology spend to gain significant attention in 2009 and beyond from both developed and emerging economies
  • 11.
    The Top TenMedTech Trends of 2009   According to Global Markets Direct Drug eluting stents on a comeback trail in the US market in 2009 Young adults and middle aged patients to drive the US market for hip resurfacing for next five years Cash rich and innovative companies to benefit in the current economic scenario Products related to women's health, minimally invasive surgery and home healthcare are set to garner special attention in 2009 High volume and low value of deals will be a norm in the medical equipment mergers and acquisitions landscape in 2009

Editor's Notes

  • #2 Quick overview of Wind River Corporate info